TABLE 1.
Strain | Serotype | MLST | Capsule genes (source/target) | Reference and/or sourcea |
---|---|---|---|---|
Isogenic capsule switch mutants | ||||
TIGR4-R | Rough | Janus cassette | 48 | |
TIGR4-1 | 1 | GA07694 | 51 | |
TIGR4-2 | 2 | GA03901 | This study | |
TIGR4-3 | 3 | GA07650 | This study | |
TIGR4 | 4 | Host strain | 47; BAA-334, ATCC | |
TIGR4-4 | 4 | TIGR4 | 51 | |
TIGR4-5 | 5 | 501 | 51 | |
TIGR4-6B | 6B | NY00216 | 48 | |
TIGR4-14 | 14 | GA02190 | 48 | |
TIGR4-19F | 19F | GA71 | 48 | |
TIGR4-23F | 23F | TN82328 | 51 | |
603-1 | 1 | GA02290 | 51 | |
603-5 | 5 | 501 | 51 | |
603-6B | 6B | Host strain | 27 | |
603-14 | 14 | GA02190 | 51 | |
603-19F | 19F | GA71 | 51 | |
618-6B | 6B | Host strain | This study | |
618-14 | 14 | GA02190 | This study | |
618-19F | 19F | GA71 | This study | |
Donors of the capsule genes | ||||
GA07694 | 1 | TIGR4 | 44; clinical isolate, ABC | |
GA02290 | 1 | 603 | 44; clinical isolate, ABC | |
GA03901 | 2 | TIGR4 | 44; clinical isolate, ABC | |
GA07650 | 3 | TIGR4 | 44; clinical isolate, ABC | |
501 | 5 | TIGR4, 603 | 51 | |
NY00216 | 6B | TIGR4 | 44; clinical isolate, ABC | |
GA02190 | 14 | TIGR4, 603, 618 | 44; clinical isolate, ABC | |
GA71 | 19F | TIGR4, 603, 618 | 6 | |
Clinical isolates sharing the same MLST but different serotypes | ||||
199-19F | 19F | 199 | 13; invasive clinical isolate | |
199-6B | 6B | 199 | 13; invasive clinical isolate | |
156-14 | 14 | 156 | 13; invasive clinical isolate | |
156-9V | 9V | 156 | 13; invasive clinical isolate | |
156-19F | 19F | 156 | 13; invasive clinical isolate | |
162-14 | 14 | 162 | 13; invasive clinical isolate | |
162-9V | 9V | 162 | 13; invasive clinical isolate | |
162-19F | 19F | 162 | 13; invasive clinical isolate | |
66-23F | 9V | 66 | 13; invasive clinical isolate | |
66-9V | 23F | 66 | 13; invasive clinical isolate |
ABC, Active Bacterial Core Surveillance of Centers for Disease Control and Prevention, Atlanta, GA. ATCC, American Type Culture Collection.